{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:07:39Z","timestamp":1793606859303,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Encapsulating peritoneal sclerosis (EPS), a condition with a high mortality rate, is a serious complication of peritoneal dialysis (PD). In Japan, EPS became a central issue in the clinical setting during the mid-90s and the beginning of this century. However, following the introduction of biocompatible neutral PD solutions containing lower levels of glucose degradation products, the incidence and clinical severity of EPS has been greatly lessened. During the past three decades, the etiology of EPS has been elucidated by findings obtained by peritoneal biopsy, laparoscopy, and surgical intervention. Accumulating findings suggest the need for a paradigm change on the nature of EPS pathophysiology; notably, EPS appears not to reflect peritoneal sclerosis per se, but rather the formation of a neo-membrane as a biological reaction to peritoneal injury. This narrative review looks back on the history of EPS in Japan, and discusses EPS pathophysiology, the impact of neutral PD solution on peritoneal protection, and a future novel diagnostic approach, ultra-fine endoscope, for the identification of patients at high risk of EPS.<\/jats:p>","DOI":"10.1007\/s10157-023-02360-y","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T18:42:34Z","timestamp":1686076954000},"page":"717-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pathophysiology of encapsulating peritoneal sclerosis: lessons from findings of the past three decades in Japan"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-8899","authenticated-orcid":false,"given":"Masaaki","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuho","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal Dialysis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"2360_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/089686089201200105","volume":"12","author":"JW Dobbie","year":"1992","unstructured":"Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int. 1992;12:14\u201327.","journal-title":"Perit Dial Int"},{"issue":"Suppl 4","key":"2360_CR2","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1177\/089686080002004S04","volume":"20","author":"Y Kawaguchi","year":"2000","unstructured":"Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000;20(Suppl 4):S43\u201355.","journal-title":"Perit Dial Int"},{"issue":"3","key":"2360_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/s0272-6386(96)90501-6","volume":"28","author":"Y Nomoto","year":"1996","unstructured":"Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis. 1996;28(3):420\u20137. https:\/\/doi.org\/10.1016\/s0272-6386(96)90501-6.","journal-title":"Am J Kidney Dis"},{"key":"2360_CR4","first-page":"119","volume":"18","author":"H Nakamoto","year":"2002","unstructured":"Nakamoto H, Kawaguchi Y, Suzuki H. Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan. Adv Perit Dial. 2002;18:119\u201323.","journal-title":"Adv Perit Dial"},{"key":"2360_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0272-6386(04)00953-9","volume":"44","author":"H Kawanishi","year":"2004","unstructured":"Kawanishi H, Kawaguchi Y, Fukui H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004;44:729\u201337.","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 3","key":"2360_CR6","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1177\/089686080102103S12","volume":"21","author":"M Nakayama","year":"2001","unstructured":"Nakayama M. The greater incidence of encapsulating peritoneal sclerosis is not the result of overdiagnosis. Perit Dial Int. 2001;21(Suppl 3):S72\u20134.","journal-title":"Perit Dial Int"},{"issue":"4","key":"2360_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s004670050758","volume":"14","author":"S Hoshii","year":"2000","unstructured":"Hoshii S, Honda M, Itami N, Oh S, Matsumura C, Moriya S, Mori M, Hatae K, Ito Y, Karashima S. Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients. Pediatr Nephrol. 2000;14(4):275\u20139.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2360_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00467-008-0982-z","volume":"25","author":"M Honda","year":"2010","unstructured":"Honda M, Warady BA. Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children. Pediatr Nephrol. 2010;25(1):75\u201381.","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"2360_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/nep.12911","volume":"22","author":"M Nakao","year":"2017","unstructured":"Nakao M, Yamamoto I, Maruyama Y, Morishita M, Nakashima A, Matsuo N, Tanno Y, Ohkido I, Ikeda M, Yamamoto H, Yokoyama K, Yokoo T. Risk factors for encapsulating peritoneal sclerosis: analysis of a 36-year experience in a University Hospital. Nephrology (Carlton). 2017;22(11):907\u201312.","journal-title":"Nephrology (Carlton)"},{"key":"2360_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000093503","volume":"150","author":"G Garosi","year":"2006","unstructured":"Garosi G, Cappelletti F, Di Paolo N. Fibrosis and sclerosis: different disorders or different stages? Contrib Nephrol. 2006;150:62\u20139.","journal-title":"Contrib Nephrol"},{"issue":"8","key":"2360_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/iju.12445","volume":"21","author":"M Nakayama","year":"2014","unstructured":"Nakayama M, Terawaki H. Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: update from Japan. Int J Urol. 2014;21(8):755\u201361.","journal-title":"Int J Urol"},{"issue":"3","key":"2360_CR12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.2215\/CJN.03630807","volume":"3","author":"K Honda","year":"2008","unstructured":"Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, Hirano H. Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal Dialysis. Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol. 2008;3(3):720\u20138.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"2360_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1744-9987.2007.00538.x","volume":"12","author":"AM Sherif","year":"2008","unstructured":"Sherif AM, Yoshida H, Maruyama Y, Yamamoto H, Yokoyama K, Hosoya T, Kawakami M, Nakayama M. Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis. Ther Apher Dial. 2008;12(1):33\u201341.","journal-title":"Ther Apher Dial"},{"key":"2360_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154644","volume":"11","author":"M Tawada","year":"2016","unstructured":"Tawada M, Ito Y, Hamada C, et al. Vascular endothelial cell injury is an important factor in the development of encapsulating peritoneal sclerosis in long-term peritoneal dialysis patients. PLoS ONE. 2016;11: e0154644.","journal-title":"PLoS ONE"},{"key":"2360_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s41100-017-0115-x","volume":"3","author":"K Honda","year":"2017","unstructured":"Honda K, Hamada C, Kawanishi K, Nakayama M, Miyazaki M, Ito Y. Significance of new membrane formation in peritoneal biopsies of peritoneal dialysis patients: a case\u2013control study. Renal Replacement Ther. 2017;3:33.","journal-title":"Renal Replacement Ther"},{"key":"2360_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.semnephrol.2016.10.010","volume":"37","author":"H Alston","year":"2017","unstructured":"Alston H, Fan S, Nakayama M. Encapsulating peritoneal sclerosis. Semin Nephrol. 2017;37:93\u2013102.","journal-title":"Semin Nephrol"},{"key":"2360_CR17","first-page":"144","volume":"18","author":"M Nakayama","year":"2002","unstructured":"Nakayama M, Yamamoto H, Ikeda M, Hasegawa T, Kato N, Takahashi H, Otsuka Y, Yokoyama K, Yamamoto R, Kawaguchi Y, Hosoya T. Risk factors and preventive measures for encapsulating peritoneal sclerosis\u2014Jikei experience 2002. Adv Perit Dial. 2002;18:144\u20138.","journal-title":"Adv Perit Dial"},{"issue":"1","key":"2360_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/pp-2016-0028","volume":"2","author":"K Kawanishi","year":"2017","unstructured":"Kawanishi K, Honda K, Hamada C. Recommendations for pathological diagnosis on biopsy samples from peritoneal dialysis patients. Pleura Peritoneum. 2017;2(1):3\u201315.","journal-title":"Pleura Peritoneum"},{"issue":"2","key":"2360_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3747\/pdi.2018.00042","volume":"39","author":"H Kawanishi","year":"2019","unstructured":"Kawanishi H, Banshodani M, Yamashita M, Shintaku S, Dohi K. Surgical treatment for encapsulating peritoneal sclerosis: 24 years\u2019 experience. Perit Dial Int. 2019;39(2):169\u201374.","journal-title":"Perit Dial Int"},{"issue":"4","key":"2360_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120174","volume":"10","author":"SM Habib","year":"2015","unstructured":"Habib SM, Abrahams AC, Korte MR, Zietse R, de Vogel LL, Boer WH, Dendooven A, Clahsen-van Groningen MC, Betjes MG. CD4-positive T cells and M2 macrophages dominate the peritoneal infiltrate of patients with encapsulating peritoneal sclerosis. PLoS One. 2015;10(4): e0120174. https:\/\/doi.org\/10.1371\/journal.pone.0120174.","journal-title":"PLoS One"},{"issue":"7","key":"2360_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1089\/wound.2012.0407","volume":"2","author":"A Sindrilaru","year":"2013","unstructured":"Sindrilaru A, Scharffetter-Kochanek K. Disclosure of the culprits: macrophages-versatile regulators of wound healing. Adv Wound Care (New Rochelle). 2013;2(7):357\u201368. https:\/\/doi.org\/10.1089\/wound.2012.0407.","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"1","key":"2360_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/ki.1991.182","volume":"40","author":"AP Wieslander","year":"1991","unstructured":"Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int. 1991;40(1):77\u20139.","journal-title":"Kidney Int"},{"issue":"1","key":"2360_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/089686089501500106","volume":"15","author":"P Kjellstrand","year":"1995","unstructured":"Kjellstrand P, Martinson E, Wieslander A, Holmquist B. Development of toxic degradation products during heat sterilization of glucose-containing fluids for peritoneal dialysis: influence of time and temperature. Perit Dial Int. 1995;15(1):26\u201332.","journal-title":"Perit Dial Int"},{"issue":"6","key":"2360_CR24","first-page":"354","volume":"42","author":"K Yamada","year":"1994","unstructured":"Yamada K, Miyahara Y, Hamaguchi K, Nakayama M, Nakano H, Nozaki O, Miura Y, Suzuki S, Tuchida H, Mimura N, et al. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Clin Nephrol. 1994;42(6):354\u201361.","journal-title":"Clin Nephrol"},{"issue":"1","key":"2360_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ki.1997.22","volume":"51","author":"M Nakayama","year":"1997","unstructured":"Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A, Kubo H, Shigematsu T, Sakai O, Horiuchi S. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int. 1997;51(1):182\u20136.","journal-title":"Kidney Int"},{"issue":"6","key":"2360_CR26","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/ndt\/14.6.1541","volume":"14","author":"K Honda","year":"1999","unstructured":"Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, Ikeda K, Horiuchi S. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant. 1999;14(6):1541\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2360_CR27","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/ndt\/gfh198","volume":"19","author":"M Nakayama","year":"2004","unstructured":"Nakayama M, Yoshimura K, Maruyama Y, Numata M, Hosoya T, Izumi G. Possible involvement of cross-linking advanced glycation endproducts in long-term CAPD peritoneal degeneration. Nephrol Dial Transplant. 2004;19(6):1664\u20135. https:\/\/doi.org\/10.1093\/ndt\/gfh198.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2360_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa020809","volume":"348","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2003","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, Lara-Pezzi E, Selgas R, Ram\u00edrez-Huesca M, Dom\u00ednguez-Jim\u00e9nez C, Jim\u00e9nez-Heffernan JA, Aguilera A, S\u00e1nchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, S\u00e1nchez-Madrid F, L\u00f3pez-Cabrera M. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med. 2003;348(5):403\u201313. https:\/\/doi.org\/10.1056\/NEJMoa020809.","journal-title":"N Engl J Med"},{"issue":"6","key":"2360_CR29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0272-6386(98)70068-X","volume":"32","author":"T Yamamoto","year":"1998","unstructured":"Yamamoto T, Izumotani T, Otoshi T, Kim M. Morphological studies of mesothelial cells in CAPD effluent and their clinical significance. Am J Kidney Dis. 1998;32(6):946\u201352.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2360_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/labinvest.3700519","volume":"87","author":"K Ksiazek","year":"2007","unstructured":"Ksiazek K, Korybalska K, J\u00f6rres A, Witowski J. Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: the role of TGF-beta1. Lab Invest. 2007;87(4):345\u201356.","journal-title":"Lab Invest"},{"issue":"3 Suppl 1","key":"2360_CR31","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1053\/ajkd.2003.50087","volume":"41","author":"S Nakamura","year":"2003","unstructured":"Nakamura S, Tachikawa T, Tobita K, Miyazaki S, Sakai S, Morita T, Hirasawa Y, Weigle B, Pischetsrieder M, Niwa T. Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients. Am J Kidney Dis. 2003;41(3 Suppl 1):S61\u20137.","journal-title":"Am J Kidney Dis"},{"key":"2360_CR32","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1046\/j.1523-1755.63.s84.31.x","volume":"84","author":"S Nakamura","year":"2003","unstructured":"Nakamura S, Tobita K, Tachikawa T, Akamatsu S, Ohno Y, Kan A, Katsuragawa M, Yasumura K, Miyazaki S, Sakai S, Morita T, Hirashawa Y, Niwa T. Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients. Kidney Int Suppl. 2003;84:S152\u20137.","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"2360_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.5414\/CNP62455","volume":"62","author":"M Numata","year":"2004","unstructured":"Numata M, Nakayama M, Hosoya T, Hoff CM, Holmes CJ, Schalling M, Nordfors L, Lindholm B. Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients. Clin Nephrol. 2004;62(6):455\u201360.","journal-title":"Clin Nephrol"},{"issue":"8","key":"2360_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/ki.2010.515","volume":"79","author":"J Perl","year":"2011","unstructured":"Perl J, Nessim SJ, Bargman JM. The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? Kidney Int. 2011;79(8):814\u201324.","journal-title":"Kidney Int"},{"issue":"12","key":"2360_CR35","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1093\/ndt\/gfs314","volume":"27","author":"DW Johnson","year":"2012","unstructured":"Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi MG, Tan SH, Voss D, balANZ Trial Investigators. The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial. Nephrol Dial Transplant. 2012;27(12):4445\u201353.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2360_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10157-004-0310-2","volume":"8","author":"M Nishina","year":"2004","unstructured":"Nishina M, Endoh M, Suzuki D, Tanabe R, Endoh H, Hirahara I, Sakai H. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Clin Exp Nephrol. 2004;8(4):339\u201343.","journal-title":"Clin Exp Nephrol"},{"key":"2360_CR37","unstructured":"Annual Dialysis Data Report 2010, The annual survey of Japanese Society for Dialysis Therapy Renal Data Registry (JRDR)."},{"key":"2360_CR38","unstructured":"Annual Dialysis Data Report 2011, The annual survey of Japanese Society for Dialysis Therapy Renal Data Registry (JRDR)."},{"key":"2360_CR39","unstructured":"Annual Dialysis Data Report 2015, The annual survey of Japanese Society for Dialysis Therapy Renal Data Registry (JRDR)."},{"key":"2360_CR40","unstructured":"Annual Dialysis Data Report 2016, The annual survey of Japanese Society for Dialysis Therapy Renal Data Registry (JRDR)."},{"issue":"5","key":"2360_CR41","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10157-015-1081-7","volume":"19","author":"A Yamahatsu","year":"2015","unstructured":"Yamahatsu A, Hamada C, Kaneko K, Io H, Nakata J, Tomino Y. Long-term outcome of encapsulating peritoneal sclerosis (EPS) patients in a single center. Clin Exp Nephrol. 2015;19(5):961\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"2360_CR42","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/ki.2012.85","volume":"82","author":"Y Tanno","year":"2012","unstructured":"Tanno Y, Yokoyama K, Hosoya T. Laparoscopic approach for the evaluation of peritoneal injury. Kidney Int. 2012;82:244\u20135.","journal-title":"Kidney Int"},{"key":"2360_CR43","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3747\/pdi.2012.00306","volume":"33","author":"Y Kamijo","year":"2013","unstructured":"Kamijo Y, Iida H, Saito K, Furutera R, Ishibashi Y. Normal peritoneum after nine years of peritoneal dialysis with biocompatible dialysate: a case report. Perit Dial Int. 2013;33:712\u20134.","journal-title":"Perit Dial Int"},{"key":"2360_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000439241","volume":"41","author":"K Sasaki","year":"2016","unstructured":"Sasaki K, et al. Laparoscopy reveals a diversity of peritoneal change in patients with long-term vintage of peritoneal dialysis. Blood Purif. 2016;41:48\u201354.","journal-title":"Blood Purif"},{"issue":"2","key":"2360_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/sdi.12870","volume":"33","author":"K Hara","year":"2020","unstructured":"Hara K, Io H, Wakabayashi K, Maeda T, Kanda R, Nakata J, Maeda K, Sengoku H, Machida M, Kojima K, Sakamoto K, Tomino Y, Suzuki Y. Multicenter laparoscopic evaluation of the peritoneum in peritoneal dialysis patients. Semin Dial. 2020;33(2):170\u20137.","journal-title":"Semin Dial"},{"key":"2360_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10047-015-0822-4","volume":"18","author":"C Hamada","year":"2015","unstructured":"Hamada C, Honda K, Kawanishi K, Nakamoto H, Ito Y, Sakurada T, Tanno Y, Mizumasa T, Miyazaki M, Moriishi M, Nakayama M. Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution. J Artif Organs. 2015;18:243\u201350.","journal-title":"J Artif Organs"},{"key":"2360_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3747\/pdi.2011.00270","volume":"33","author":"K Kawanishi","year":"2013","unstructured":"Kawanishi K, Honda K, Tsukada M, Oda H, Nitta K. Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis. Perit Dial Int. 2013;33:242\u201351.","journal-title":"Perit Dial Int"},{"issue":"5","key":"2360_CR48","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10157-018-1679-7","volume":"23","author":"M Tawada","year":"2019","unstructured":"Tawada M, Hamada C, Suzuki Y, Sakata F, Sun T, Kinashi H, Katsuno T, Takei Y, Maruyama S, Honda K, Mizuno M, Ito Y. Effects of long-term treatment with low-GDP, pH-neutral solutions on peritoneal membranes in peritoneal dialysis patients. Clin Exp Nephrol. 2019;23(5):689\u201399.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"2360_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/0896860820954972","volume":"41","author":"R Oba","year":"2021","unstructured":"Oba R, Matsuo N, Honda Y, Furuya M, Maruyama Y, Tanno Y, Ohkido I, Yokoo T. Twenty-seven years of peritoneal dialysis with preserved peritoneal morphology: a case report with autopsy. Perit Dial Int. 2021;41(1):129\u201331.","journal-title":"Perit Dial Int"},{"key":"2360_CR50","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3747\/pdi.2013.00074","volume":"34","author":"M Nakayama","year":"2014","unstructured":"Nakayama M, Miyazaki M, Honda K, Kasai K, Tomo T, Nakamoto H, Kawanishi H. Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: The NEXT-PD study. Perit Dial Int. 2014;34:766\u201374.","journal-title":"Perit Dial Int"},{"issue":"Suppl. 3","key":"2360_CR51","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1177\/089686080802803s37","volume":"28","author":"Y Maruyama","year":"2008","unstructured":"Maruyama Y, Nakayama M. Encapsulating peritoneal sclerosis in Japan. Perit Dial Int. 2008;28(Suppl. 3):S201\u20134.","journal-title":"Perit Dial Int"},{"key":"2360_CR52","unstructured":"Position statement. Peritoneal Dialysis Guidelines 2019 Part 1. Chapter 5 Discontinuation of peritoneal dialysis to avoid encapsulating peritoneal sclerosis. Renal Replacement Ther 2021;7:40."},{"key":"2360_CR53","first-page":"131","volume":"18","author":"R Yamamoto","year":"2002","unstructured":"Yamamoto R, Nakayama M, Hasegawa T, Numata M, Yamamoto H, Yokoyami K, Ikeda M, Kato N, Hayakawa H, Takahashi H, Otsuka Y, Kawaguchi Y, Hosoya T. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment. Adv Perit Dial. 2002;18:131\u20134.","journal-title":"Adv Perit Dial"},{"key":"2360_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/1744-9987.12048","volume":"18","author":"M Nakao","year":"2014","unstructured":"Nakao M, Yokoyama K, Yamamoto I, et al. Risk factors for encapsulating peritoneal sclerosis in long-term peritoneal dialysis: a retrospective observational study. Ther Apher Dial. 2014;18:68\u201373.","journal-title":"Ther Apher Dial"},{"issue":"1","key":"2360_CR55","doi-asserted-by":"publisher","first-page":"17565","DOI":"10.1038\/s41598-020-74129-2","volume":"10","author":"M Nakayama","year":"2020","unstructured":"Nakayama M, Hamada C, Yokoyama K, Tanno Y, Matsuo N, Nakata J, Ishibashi Y, Okuzawa A, Sakamoto K, Nara T, Kakuta T, Nangaku M, Yokoo T, Suzuki Y, Miyata T. A disposable, ultra-fine endoscope for non-invasive, close examination of the intraluminal surface of the peritoneal dialysis catheter and peritoneal cavity. Sci Rep. 2020;10(1):17565. https:\/\/doi.org\/10.1038\/s41598-020-74129-2.","journal-title":"Sci Rep"},{"issue":"4","key":"2360_CR56","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4009\/jsdt.31.303","volume":"31","author":"Y Nomoto","year":"1998","unstructured":"Nomoto Y, et al. Sclerosing encapsulating peritonitis (SEP) in patients on continuous ambulatory peritoneal dialysis\u2014definition, diagnosis and treatment recommendations, 1997 update. J Jpn Soc Dial Ther. 1998;31(4):303\u201311 (in Japanese).","journal-title":"J Jpn Soc Dial Ther"},{"issue":"Suppl 4","key":"2360_CR57","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1177\/089686080502504S12","volume":"25","author":"Y Kawaguchi","year":"2005","unstructured":"Kawaguchi Y, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int. 2005;25(Suppl 4):S83-95.","journal-title":"Perit Dial Int"},{"key":"2360_CR58","doi-asserted-by":"crossref","unstructured":"2009 Japanese Society for Dialysis Therapy guidelines for peritoneal dialysis. Ther Apher Dial. 2010;14(6):489\u2013504.","DOI":"10.1111\/j.1744-9987.2010.00901.x"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-023-02360-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T03:22:53Z","timestamp":1692242573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-023-02360-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2360"],"URL":"https:\/\/doi.org\/10.1007\/s10157-023-02360-y","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"12 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lecture fees: MN, Terumo Limited; YI, Baxter Limited. Donation: YI, Baxter Limited. The other authors (MM, CH, and KH) have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}